Skip to main content
Industry News
Coronavirus to have mixed impact on pharma supply chain

The current coronavirus outbreak in China could cause a potential supply chain disruption for US biopharma companies, although some key players such as Bayer and Johnson & Johnson say they have policies in place to minimize disruption. The industry is expecting a mixed impact depending on the type of drugs the pharma company produces, according to credit rating service Moody's.

Full Story: